HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis.

AuthorsAnne-Fleur Louise Van der Paardt, Onno W Akkerman, Gina Gualano, Fabrizio Palmieri, Lina Davies Forsman, Alena Aleksa, Simon Tiberi, Wiel C M de Lange, Mathieu S Bolhuis, Alena Skrahina, Dick van Soolingen, Jos G W Kosterink, Giovanni Battista Migliori, Tjip S van der Werf, Jan-Willem C Alffenaar
JournalThe European respiratory journal (Eur Respir J) Vol. 49 Issue 3 (03 2017) ISSN: 1399-3003 [Electronic] England
PMID28331034 (Publication Type: Letter)
Chemical References
  • Antitubercular Agents
  • Clarithromycin
Topics
  • Adult
  • Antitubercular Agents (administration & dosage, adverse effects)
  • Clarithromycin (administration & dosage, adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis (isolation & purification)
  • Recurrence
  • Sputum (microbiology)
  • Tuberculosis, Multidrug-Resistant (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: